NRT

Smoking Cessation Products

June 2026: FDA Delays Approval of Achieve’s Cytisinicline Over Manufacturing Issues The U.S. Food and Drug Administration (FDA) has declined to approve Achieve Life Sciences’s smoking cessation drug cytisinicline, issuing a Complete Response Letter that cites unresolved issues at a third-party manufacturing facility and incomplete product labeling. Importantly, the agency

Read More »

Zonnic: Canada

March 2026: Alberta Urges Federal Government to Ease Nicotine Pouch Restrictions Amid Black Market Concerns Alberta’s provincial government has formally urged Canada’s federal authorities to reconsider strict national rules governing nicotine pouches, arguing that the current framework is counterproductive and contributes to the growth of an unregulated market. In a

Read More »

Nicotine gum

Nicotine gum is an over-the-counter nicotine replacement therapy (NRT) product designed to help smokers quit by gradually reducing their nicotine dependence. It provides a controlled and lower dose of nicotine compared to cigarettes, without the harmful tar, carbon monoxide, and other toxic chemicals present in tobacco products. Nicotine gum works

Read More »

Quit smoking – Stop smoking

Myths and Facts About Nicotine Nicotine is often misunderstood. Some people believe it causes cancer. Others think switching to nicotine alternatives is just as harmful. The truth is that many myths are stopping smokers from making better choices about their health. Whether you’re thinking about quitting or just curious, this

Read More »

Nicotine Lozenges

Quitting smoking is no small feat – it’s a journey filled with challenges and triumphs. But what if there was a simple, effective way to ease the transition? Enter nicotine lozenges, a tool designed to help you say goodbye to smoking for good. These lozenges provide an accessible, smoke-free method

Read More »

Call Request:
Reports

We will reach out to you within 24 hours to discuss your request. Please note that we only respond to requests with a valid business e-mail address
Disclaimer: The content in our Market Pulse section is/shall not be construed as investment advice. It is for informative purposes only and does not take into account the individual needs, investment objectives and specific financial circumstances. Any action taken upon the information in our Market Pulse section is strictly at the reader’s own risk. We assume no responsibility or liability for the actions taken. Moreover, we also assume no responsibility or liability for any errors or omissions in our content – which is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness even if we only depend on the infromation sources that are believed to be accurate.

Consultation
Session Request

We will reach out to you within 24 hours to discuss your request. Please note that we only respond to requests with a valid business e-mail address